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Receptors for extracellular ATP (both ionotropic and metabotropic) are widely expressed in
the CNS both in neurones and glia. ATP can modulate neuronal activity in many parts of the
brain and contributes to the central nervous control of several physiological functions. Here we
show that during the systemic inﬂammatory response the extracellular concentrations of ATP
increase in the anterior hypothalamus and this has a profound effect on the development of the
thermoregulatory febrile response. In conscious rabbits we measured ATP release in real time
with novel amperometric biosensors and monitored a marked increase in the concentration
of ATP (4.0±0.7μM) in the anterior hypothalamus in response to intravenous injection of
bacterial endotoxin – lipopolysaccharide (LPS). No ATP release was observed in the posterior
hypothalamus. The release of ATP coincided with the development of the initial phase
of the febrile response, starting 18±2min and reaching its peak 45±2min after LPS
injection. Application of the ATP receptor antagonists pyridoxal-5 -phosphate-6-azophenyl-
2 ,4 -disulphonic acid, Brilliant Blue G or periodate oxidized ATP dialdehyde to the site of ATP
release in the anterior hypothalamus markedly augmented and prolonged the febrile response.
These data indicate that during the development of the systemic inﬂammation, ATP is released
intheanteriorhypothalamustolimitthemagnitudeanddurationoffever.Thisreleasemayalso
have a profound effect on the hypothalamic control of other physiological functions in which
ATP and related purines have been implicated to play modulatory roles, such as food intake,
hormone secretion, cardiovascular activity and sleep.
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Development of the systemic inﬂammatory response
during infection is accompanied by a number of
behavioural and autonomic responses, such as a decrease
in activity, sleepiness, malaise, fever and loss of appetite.
The behavioural and autonomic symptoms of sickness
represent a highly organized strategy to ﬁght infection
(Hart, 1988; Kluger, 1991; Dantzer, 2004). These adaptive
responses are orchestrated by the central nervous system
and are believed to be mediated by proinﬂammatory
cytokines (such as interleukin (IL)-1β and others) that
are temporarily expressed and produced in the CNS
during infection. However, the exact mechanism that is
responsible for triggering expression of cytokines in the
brainduringthedevelopmentoftheinﬂammatoryprocess
in the periphery is not entirely clear (for a discussion of
thepossiblemechanismsseeDantzer,2004andContietal.
2004).
Extracellular ATP can induce release of IL-1β, tumour
necrosis factor-α and other cytokines from glia (Hide
et al. 2000; Inoue, 2002; Chakfe et al. 2002; Suzuki et al.
2004; Kucher & Neary, 2005). Ionotropic P2X7 receptors
have been shown to mediate ATP-induced release of
cytokines by activated glial cells (Hide et al. 2000; Chakfe
et al. 2002; North, 2002; Suzuki et al. 2004; Khakh &
North, 2006; Choi et al. 2007). Recently Choi et al. (2007)
demonstrated that systemic inﬂammation induced in
rats following intraperitoneal administration of bacterial
endotoxin – lipopolysaccharide (LPS) – is accompanied
by marked up-regulation in P2X7 receptor expression in
the brain. In our recent study in rats we observed that
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systemic blockade of P2X7 receptors attenuates both fever
and increases in plasma cytokine levels evoked by LPS in
rats (Gourine et al. 2005c).
However, extracellular ATP is not just a
cytokine-inducing signalling molecule. Speciﬁc ATP
receptors,bothionotropicP2XandmetabotropicP2Y,are
widely expressed in the CNS by both neurones and glia.
AtsomeCNSsynapsesATPactsasafastneurotransmitter
(for reviews see North, 2002; Khakh & North, 2006;
Burnstock, 2007). ATP can modulate neuronal activity
in many parts of the brain and contribute to the central
nervous control of several physiological functions, such
as body temperature regulation (Gourine et al. 2002b,
2004), cardiovascular (Spyer et al. 1997; Scislo & O’Leary,
2005) and respiratory control (Gourine et al. 2005a,b;
Gourine, 2005) and others.
This clear functional role of extracellular ATP in the
central nervous control of autonomic functions as well
as its ability to induce cytokine release from glia, suggest
thatATP-mediatedsignallinginthebrainduringsystemic
inﬂammation may play an important role (either directly
or indirectly, via induction of cytokine release) in the
manifestation of behavioural and autonomic symptoms
of sickness. Of these symptoms, fever – a regulated rise in
bodytemperature(Tb)–isoneofthemostfundamental.It
represents an adaptive thermoregulatory response aimed
at facilitating host resistance and slowing the growth
of the pathogen. Fever is orchestrated by the preoptic
area/anteriorhypothalamicstructuresandisbelievedtobe
inducedbytheactionsofproinﬂammatorycytokines(such
as IL-1β) in the anterior hypothalamus (Klir et al. 1994;
Kluger et al. 1995; Gourine et al. 1998). In experimental
animals, the magnitude of fever usually correlates well
with the severity of the underlying inﬂammatory process
and can be easily monitored by measuring core Tb.T o
test our hypothesis we induced systemic inﬂammation in
conscious rabbits and measured, in real time, changes
in extracellular concentration of ATP and its break-
down product adenosine in the anterior and posterior
hypothalamic regions. To ascertain the functional role
of ATP released during fever, we applied ATP receptor
antagonists to the sites of release and the effect of this
treatment on the development of the febrile response was
determined.
Methods
Animals
Adult male Chinchilla rabbits weighing 2.7–3.2kg were
used in this study (n=136). They were housed in a room
maintained at a constant temperature of 21±1◦C and in
a 12:12h light–dark cycle with light onset at 06.00h.
Drinking water and food were provided ad libitum.
All studies on conscious rabbits were conducted in the
facilities of the Institute of Physiology, National Academy
ofSciencesofBelarusandwereapprovedandgovernedby
the Institutional Animal Care and Use Committee.
Surgery
Rabbits were anaesthetized with a mixture of ketamine
hydrochloride (45mgkg−1, s.c.) and xylazine
hydrochloride (10.0mgkg−1, s.c.) with additional
ketamine (20mgkg−1 s.c.) administered every 30min if
necessary. A miniature temperature-sensitive telemetry
transmitter (modelE-mitter, Minimitter, Sunriver, OR,
USA) was implanted into the abdominal cavity of each
animal for continuous monitoring of Tb. Then the head
of the rabbit was placed in a David Kopf stereotaxic
apparatus and two 20-gauge guide cannulae (Plastics
One,Roanoke,VA,USA)wereimplantedeitherbilaterally
into the anterior hypothalamus (stereotaxic co-ordinates:
0.5mm rostral to bregma, 2.5mm lateral to midline)
or bilaterally into the posterior hypothalamus (2.5mm
caudal to bregma, 2.5mm lateral to midline) according
to the atlas of Sawyer et al. (1954). Each guide cannula
was lowered 8mm from the cortical surface so that
the tip was positioned 6mm dorsal to the desired
recording/microinjection sites. Two small screws were
placedintotheskull,andthecannulawassecuredinplace
by dental acrylic. The guide cannula was closed with a
dummy cannula that extended from the tip of the guide
cannula by ∼1mm. After surgery, rabbits were housed
one per cage, were given penicillin and lidocaine and
were allowed to recover for at least 7days before any
experiment. At the end of the experiment the animals
were killed humanely by an overdose (200mgkg−1)o f
pentobarbitone sodium injected intraperitoneally (i.p.),
thebrainswereremovedandthelocationsoftherecording
andinjectionsiteswereconﬁrmedhistologically(Fig.1C).
ATP and adenosine biosensors
The principal design and operation of the enzyme-based
ATP and adenosine biosensors have been described in
detail elsewhere (Llaudet et al. 2003, 2005). ATP detection
is based on the use of two enzymes, glycerol kinase
and glycerol-3-phosphate oxidase, entrapped within a
polymer matrix around a ﬁne Pt wire. In the presence of
glycerol these two enzymes convert ATP to H2O2 which
is detected electrochemically (detection limit 100nm
ATP). To measure changes in adenosine concentration
the biosensor’s enzymatic cascade was comprised of
adenosine deaminase, nucleoside phosphorylase and
xanthine oxidase that successively converts adenosine
to inosine, and then xanthine which is oxidized to
uric acid with the evolution of H2O2. Thus, currents
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generated by the adenosine sensor may represent changes
inlocalconcentrationsofeitheradenosine,inosineand/or
hypoxanthine/xanthine. Therefore, in our experiments,
inosine sensors (i.e. sensors containing just nucleoside
phosphorylase and xanthine oxidase) were used in dual
recordingconﬁgurations(below)alongwiththeadenosine
sensors. The differences between adenosine and inosine
sensor currents indicated changes in adenosine levels.
The selectivity of the biosensors was improved by
incorporation of an inner layer of 1,3phenylene diamine,
to screen out the majority of electroactive interferences
such as ascorbate, urate and catecholamine transmitters.
In this study the sensor assembly was custom-made
using dummy cannula supplied by Plastics One (Fig.1A).
This dummy cannula has a rigid stainless steel wire and
rounded plastic cap which screws onto the guide cannula
threaded post. Fine (125μm) Teﬂon-coated Pt wire was
spiralledaroundandgluedtothestainlesssteelcentralwire
of the dummy cannula. The very tip (∼1mm in length)
of the Pt wire was stripped of Teﬂon and covered with
sensitive enzyme-polymer layer.
It is well known that electrochemical biosensors can
respond – in addition to the analyte of interest – to many
electroactive species in the millieu. Therefore, in all the
experiments, we used a dual recording conﬁguration of
the ATP or adenosine sensor placed into one side of the
hypothalamus along with a null sensor, lacking essential
Figure 1. ATP biosensors and their
placements in the rabbit hypothalamus
A, scheme of the sensor assembly and
calibration curve of the ATP biosensor. An
expanded portion of the sensor is shown to
indicate the enzymatic biolayer. Note that this
biolayer completely surrounds the tip of the Pt
wire. Calibration curve of the ATP biosensor
demonstrates linearity of ATP detection in
concentrations from 1 to 50 μM. B, schematic
showing the placement of the sensors in the
anterior hypothalamus of the rabbit. A dual
recording conﬁguration of ATP or adenosine
sensor placed upon one side of the
hypothalamus along with a null or inosine
sensor that was placed in an equivalent position
on the other side of the hypothalamus was
used (see main text for details). C, histological
identiﬁcation of the sensor placements in the
anterior (left) and posterior (right)
hypothalamus. 3V, third cerebral ventricle; AH,
anterior hypothalamic area; f, fornix; LH, lateral
hypothalamic area; M, mammillary nuclei; MRe,
mammillary recess of the third ventricle; OX,
optic chiasm; SuM, supramammillary area.
Arrows indicate track of the sensor.
enzymes, that was placed in an equivalent position on
the other side of the hypothalamus (Fig.1B). Thus, the
null sensor served as a control to determine whether any
‘non-speciﬁc’ electroactive interferents were released and
couldhaveconfoundedthemeasurements.Inosinesensors
were used in dual recording conﬁgurations along with
the adenosine sensors to detect changes in inosine levels.
The development of a normal thermoregulatory febrile
response during systemic inﬂammation in rabbits was
found to be unaffected when biosensor recording have
beenmadefromeitheranteriororposteriorhypothalamic
regions.
Biosensors were calibrated in vitro immediately prior
to and after the recordings. To convert changes in sensor
current to changes in ATP and adenosine concentrations,
the mean of the initial and ﬁnal calibrations was used.
Injections into the hypothalamus
Animals were conditioned to handling once a day for
5–6days prior to the experiment. Microinjections (2μl
volume) were made over a period of 1–2min using an
internal injection cannula connected to PE-50 tubing
attached to a 10μl syringe (Hamilton, Reno, NV, USA).
The injection cannula was removed 2–3min after the
injection.
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Induction of systemic inﬂammation accompanied
by the febrile response
Puriﬁed LPS (Escherichia coli endotoxin 0111:B4, Sigma
Chemical, St Louis, MO, USA) was dissolved in
pyrogen-freesalineandinjectedintoanearveinatadoseof
0.5μgkg −1andinavolumeof∼0.2ml.Theseinjectionsof
smallamountsofLPSdidnotcauseanysigniﬁcantdistress
or lasting harm in rabbits. All animals recovered very well
and appeared normal by 8h after the injections.
Drugs
Generic P2 receptor blocker pyridoxal-5 -phosphate-
6-azophenyl-2 ,4 -disulphonic acid (PPADS) and
the compounds generally regarded as P2X7 receptor
antagonists – Brilliant Blue G (BBG) and periodate
oxidized ATP dialdehyde (oATP) – were obtained from
Sigma Chemical. The compounds were dissolved in
artiﬁcial cerebrospinal ﬂuid (aCSF) to the designed
concentration in 2μl volume. The aCSF used for
injections consisted of (mm): 145.0 NaCl, 3.3 KCl, 1.3
CaCl2 and 1.0 MgCl2 dissolved in sterile pyrogen-free
water.
Experimental protocols
Measurements of the changes in ATP and adenosine
concentration in the anterior and posterior hypothalamic
regions. Animals were conditioned to sit quietly in the
restrainer for several hours each day for 5–6days prior to
the experiment. On the day of the experiment the rabbit
was placed in the restrainer, the dummy cannula was
unscrewed and 5μl of aCSF containing glycerol (5mm)
essentialforATPbiosensoroperationwasinjectedintothe
recording site. The whole length of the guide cannula was
then ﬁlled with aCSF containing glycerol; the biosensor
assembly was carefully lowered through the cannula into
the desired recording site and ﬁrmly screwed onto the
guide cannula threaded post. Preliminary studies did not
reveal any effect of glycerol-enriched aCSF applied to the
anteriororposteriorhypothalamusonanimal’sbehaviour,
body temperature or ability to develop fever in response
to LPS. A thin Ag–AgCl reference electrode was placed
under local anaesthesia (1% lidocaine) into the soft tissue
under the skin on the animal’s forehead. The sensors were
connected to a MicroC potentiostat (WPI, Sarasota, FL,
USA)andaperiodof20–30minwasallowedforsensorsto
polarize. To induce systemic inﬂammation, accompanied
byfever,LPSwasgivenintravenouslyasdescribedabove.In
our initial experiments when recordings were conducted
for 3–4h after LPS challenge we noticed that ATP release
in the anterior hypothalamus is relatively transient and
occurs only during the initial phase of fever. Therefore,
in all subsequent experiments we limited the duration of
the recordings to the ﬁrst 2h following LPS injections.
Changes in hypothalamic adenosine concentration were
monitored for up to 4h after induction of inﬂammation.
At the end of the experiment the sensors were carefully
removed and immediately calibrated to test whether
they retained sensitivity. Recording sites were identiﬁed
histologicallyandmappedusingastereotaxicatlas(Sawyer
et al. 1954). Histological analysis of the sensor placements
conﬁrmed that recording sites were within the targeted
regionsoftheanterior(anteriorhypothalamicandmedial
preoptic areas) and posterior (supramammillary area and
mammillary nuclei) hypothalamus (Fig.1C).
Effect of ATP receptor blockade in the anterior
and posterior hypothalamus on the febrile response
during systemic inﬂammation. These experiments were
conducted in unrestrained rabbits, which were kept in
their cages. The animals were prepared as described
above (see Surgical procedure). Body temperature was
monitored using biotelemetry. ATP receptor antagonists
(either PPADS (10μg), BBG (10μg) or oATP (10 and
100μg)) were injected unilaterally into the designated
hypothalamic site 5min prior to LPS or saline treatment.
Control animals were given aCSF (2μl) also followed
by intravenous administration of LPS or saline. Tb was
monitored for 1h before and 6h after LPS or saline
injections, which were performed between 09.00 and
10.00h. At the end of the experiments the injection sites
weremarkedbyinjectionsofPontamineSkyBluedye(2%
in0.2msodiumacetate,2μl)andidentiﬁedhistologically.
Statistical analysis
Records of changes in ATP and adenosine levels were
processedandanalysedusingSpike2software(Cambridge
ElectronicDesign,Cambridge,UK).ChangesinATPlevels
are presented as means±standard error (s.e.m.) of peak
(inμm)andintegral(inμms)increasesinconcentrations.
The integral increases in ATP levels were estimated by
measuring the area under the curve relative to a straight
line joining the sensor current before and after the
response.Temperaturedataarereportedasmeans±s.e.m.
Comparisons between experimental groups were made
for each time point using analysis of variance (ANOVA)
followedbytheTukey–Kramer’sposthoc testtodetermine
the main group effect. A value of P <0.05 was considered
to be signiﬁcant.
Results
Measurements of the changes in ATP and adenosine
concentrations in the anterior and posterior
hypothalamic regions
Thebiosensorswerepolarizedtotheiroperatingpotential
(+500mV with respect to Ag–AgCl) immediately
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followingtheirplacementintothetissuethroughtheguide
cannula. This resulted in a quasi-exponential decaying
currentseenattheonsetofthebiosensorrecordings(Figs2
and 3). This decaying current is largely faradaic. The
fastest components of the decay are usually completed by
15–20minfollowingpolarizationalthoughsomeveryslow
decaywilloccurthroughouttherecordings(cf.Nullsensor
records, Fig. 2). It is important to note that this decay of
the background current is inherent in the amperometric
measurement technique and does not represent a drop in
analyte concentration.
During the development of systemic inﬂammation
ATP microelectrode biosensors placed into the anterior
hypothalamic region responded with a large increase
in current above the baseline, that started 18±2min
after intravenous injection of LPS (mean signal: peak
1.1±0.1nA, integral 322±70nA·s; n=9; Fig.2A). Null
sensors that lacked enzymes in the polymer coating
displayed only small ﬂuctuations of the current around
Figure 2. Release of ATP in the anterior
hypothalamus during the development of the
systemic inﬂammatory response in rabbits
Representative raw data illustrating changes in ATP
and null sensor currents and development of fever
(increase in core body temperature (Tb) shown in
the bottom traces) following intravenous
administration of bacterial endotoxin –
lipopolysaccharide (LPS, 0.5 μgk g −1) when the
sensors were placed in the anterior (A) and
posterior (B) hypothalamic regions. Downward
parallel shifts in the ATP and null sensor currents
represent slow continuous polarization of the
sensors during the whole experiment. X-axis
denotes time after LPS injection. Arrow points to
the moment when concentration of ATP starts to
increase above the baseline.
thebaseline.ThechangesinATPsensorcurrentstherefore
indicate an increase in the extracellular concentration
of ATP in the anterior hypothalamus that had a mean
amplitude of 4.0±0.7μm (n=9). The release of ATP
reached its peak 45±2min after LPS injections and
the total amount of ATP released in this part of
the brain in the ﬁrst 120min of the development of
the systemic inﬂammatory response was estimated to
be 1179±292μm·s( n=9). Biosensors placed into the
posterior hypothalamus failed to detect any signiﬁcant
changes in extracellular concentration of ATP in response
to intravenous injection of LPS (Fig.2B).
In three out of six rabbits LPS also evoked marked
increases in adenosine concentration in the anterior
hypothalamus. Figure3 depicts the time-course of
LPS-induced adenosine release (top trace). The increase
in adenosine concentration occurred 55±7min (n=3)
andpeaked191±2min(n=3)afterLPSchallenge.Thus,
the time-course of adenosine release during systemic
C   2007 The Authors. Journal compilation C   2007 The Physiological Society310 A. V. Gourine and others J Physiol 585.1
inﬂammationwassubstantiallydifferentfromthatofATP.
This increase in adenosine sensor current had a mean
amplitude of 1.8±0.6nA (n=3) and was followed by
a delayed increase in the inosine sensor current which
was recorded in an identical position on the contralateral
side of the anterior hypothalamus (Fig. 3). These data
indicatethatadenosineisreleasedﬁrstandthenconverted
to inosine. If this signal was purely due to the release
of adenosine, it would be equivalent to 5.8±0.2μm.
No adenosine (or inosine) release from the posterior
hypothalamic structures was detected in a further ﬁve
rabbits.
Effect of ATP receptor blockade in the anterior and
posterior hypothalamus on the febrile response
during systemic inﬂammation
Systemic inﬂammation induced in rabbits following
intravenous treatment with LPS is accompanied by the
development of the profound febrile response (Figs4 and
5). We tested the effects of a range of ATP receptor
antagonists injected into the anterior hypothalamus
immediately prior to LPS administration. Thus, by the
time of LPS challenge ATP receptors have already been
affected at the hypothalamic sites which exhibited ATP
release during systemic inﬂammation. All ATP receptor
antagonists used had a delayed effect on fever – the febrile
responsewasprolongedandthemagnitudeofitslatephase
was signiﬁcantly augmented (Fig. 4). Administration of
BBG into the anterior hypothalamus potentiated fever
90–360min after LPS challenge (P =0.019, compared
with the aCSF/LPS group). Tb of febrile rabbits that had
PPADS injected into the anterior hypothalamus was also
signiﬁcantlyhighercomparedwiththatofanimalsinjected
with aCSF 150–360min following LPS administration
(P =0.014). oATP (at a higher dose of 100μg) had a
less profound, yet signiﬁcant, effect on Tb during the
Figure 3. Release of adenosine and inosine in
the anterior hypothalamus during the
development of the systemic inﬂammatory
response in rabbits
Raw data illustrating changes in adenosine and
inosine sensor currents and development of fever
(increase in core Tb) following intravenous
administration of LPS (0.5 μgk g −1). The sensors
were placed in the anterior hypothalamus.
Downward shifts in sensor currents represent
polarization of the sensors. X-axis denotes time
after LPS injection. Arrows point to the moments
when concentrations of adenosine and inosine start
to increase above the baseline.
late phase of the febrile response: 240–360min after
LPS injection the Tb of animals treated with oATP was
signiﬁcantly (P =0.023) higher compared with controls.
Thus,alloftheanimalstreatedwithBBG,PPADSoroATP
into the anterior hypothalamus remained febrile 6h after
induction of systemic inﬂammation by intravenous LPS
challenge.
PPADS and oATP (10μg) administered into the
posterior hypothalamus had no effect on LPS-induced
febrile response (Fig. 5). Injection of oATP in a higher
dose of 100μg resulted in a small potentiation of fever
at the very late stages of the febrile response (comparison
with controls at 315–360min, P =0.020, Fig. 5).
Injections of BBG, PPADS or oATP into either anterior
or posterior hypothalamic regions had no effect on Tb in
afebrile animals (Figs4 and 5).
Discussion
This study performed in conscious animals has
demonstrated for the ﬁrst time that during the
development of the systemic inﬂammatory response,
extracellular concentration of the purine nucleotide ATP
increases in the anterior hypothalamus and this has
a profound effect on the proﬁle of the accompanying
thermoregulatory febrile response. This release of ATP
coincides with the development of the initial phase of
fever and appears to be also followed by increases in
hypothalamicadenosineandtheninosineconcentrations.
ATP receptor antagonists administered to the site of ATP
release all markedly augmented and prolonged the febrile
response. This ﬁnding suggests that ATP, released in the
anterior hypothalamus during systemic inﬂammation,
is acting locally as an endogenous antipyretic mediator
limiting the magnitude and the duration of the febrile
response. Notably, ATP release was not seen in the
posterior hypothalamus.
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Figure 4. P2 receptor antagonists administered to the site of ATP release augment and prolong the
febrile response during systemic inﬂammation in rabbits
The graphs illustrate the effects of Brilliant Blue G (BBG), pyridoxal-5 -phosphate-6-azophenyl-2 ,4 -disulphonic
acid (PPADS) and periodate-oxidized ATP (oATP) on body temperature during systemic inﬂammation induced in
rabbits by intravenous injection of LPS (0.5 μgk g −1). BBG (10 μg), PPADS (10 μg), oATP (10 and 100 μg) or aCSF
were injected unilaterally into the anterior hypothalamus 5 min prior to LPS administration. Data are presented
as means ± S.E.M. Numbers in parentheses indicate sample sizes. Arrowheads indicate time of injections. For
presentation purposes the temperature curves of BBG + LPS, PPADS + LPS, oATP + LPS, BBG + saline, PPADS +
saline, and oATP + saline are shown on separate plots along with the temperature curves of the same respective
controlgroups(aCSF+LPSoraCSF+saline). ∗BBGhadsigniﬁcant(P < 0.05)increasingeffectonbodytemperature
75–360 min, PPADS – 150–360 min and oATP (100 μg) – 240–360 min after initiation of the febrile response by
intravenous LPS challenge.
C   2007 The Authors. Journal compilation C   2007 The Physiological Society312 A. V. Gourine and others J Physiol 585.1
Technical considerations
This is the ﬁrst in vivo study in conscious animals to
utilize enzyme-based biosensors to monitor in real-time
the release of ATP and adenosine from the structures
located deep in the brain. In our earlier studies in
anaesthetized rats, we used biosensors to determine
in various physiological conditions changes in ATP
and adenosine concentrations in the structures located
close to the exposed surface of the brain (Dale et al.
2002; Gourine et al. 2002a, 2005a,b). Here we have
demonstrated that purine biosensors can be used for
long-term measurements of ATP and adenosine levels in
thedeepbrainstructuresinunanaesthetizedexperimental
animals.
TheATPbiosensorrespondsimmediatelytochangesin
ATP concentration and has a 10–90% response time of
<10s (Llaudet et al. 2005). Thus, the sensors will quickly
Figure 5. The effects of P2 receptor antagonists administered into the posterior hypothalamus on the
febrile response during systemic inﬂammation in rabbits
The graphs illustrate the effects of PPADS and oATP on body temperature during systemic inﬂammation induced in
rabbits by intravenous injection of LPS (0.5 μgk g −1). PPADS (10 μg), oATP (10 and 100 μg) or aCSF were injected
unilaterallyintotheposteriorhypothalamus5 minpriortoLPSadministration.Dataarepresentedasmeans ± S.E.M.
Numbers in parentheses indicate sample sizes. Arrowheads indicate time of injections. For presentation purposes
the temperature curves of PPADS + LPS, oATP + LPS, PPADS + saline, and oATP + saline are shown on separate
plots along with the temperature curves of the same respective control groups (aCSF + LPS or aCSF + saline).
∗oATP in a high dose of 100 μg had signiﬁcant (P < 0.05) increasing effect on body temperature 315–360 min
after LPS injection.
and accurately reﬂect the dynamic of changes in ATP
concentration in the vicinity of the sensor. We found that
duringsystemicinﬂammationthepeakincreaseinanterior
hypothalamic ATP concentration reaches ∼4μm. This
increase represents a dramatic elevation of extracellular
ATP level over its basal concentration in the brain, which
is estimated to be in the low nanomolar range (Phillis
& O’Regan, 2002; Melani et al. 2005). Release of ATP
coincides with the beginning of fever starting ∼18min
and reaching its peak ∼45min after LPS injection. This
increase in ATP concentration was found to be relatively
transient,decreasingbacktobaselinewithin120minafter
LPS administration.
Although ATP biosensors require glycerol to operate,
their responses are insensitive to variations in glycerol
concentration over the range of 0.5–5mm (Llaudet
et al. 2005). To provide sensors with sufﬁcient glycerol,
recording sites were preinjected and the guide cannula
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was ﬁlled with glycerol-enriched aCSF. Although, ATP
sensors retained >70% of their initial sensitivity at the
end of the experiment, the rate of glycerol washout
from the recording site is unknown. If glycerol were
to be rapidly diluted and washed away then the time
to peak and the amount of ATP released may be
signiﬁcantly underestimated. However, this is unlikely
because the enzyme–polymer layer of the biosensor has
the ability to entrap and retain glycerol in amounts
sufﬁcient for the sensor to operate. Controls in which
ATP biosensors soaked in 5mm glycerol solution
and then washed and repeatedly tested with ATP in
glycerol-free media demonstrated that these biosensors
retain their full sensitivity to ATP for up to 4h (N. Dale,
unpublished observations). These observations suggest
that the time-course and the amount of ATP measured in
our experiments represent quite accurately the dynamics
of ATP release in the anterior hypothalamus.
In addition, if ATP were to be rapidly broken down
to adenosine then measurements of the extracellular
adenosine may also reﬂect the time-course of changes
in ATP concentration. However, signiﬁcant release of
adenosine in the anterior hypothalamus during systemic
inﬂammation was observed in only 3 out of 6 animals
tested. It is not entirely clear why the remaining three
animals showed no changes in adenosine concentration.
All adenosine sensors retained ∼40% of their initial
sensitivity at the end of the experiment and histological
analysis of the sensor placements showed that the
recording sites in all six cases were within the same
general area of the anterior hypothalamus. It is likely that
a high baseline concentration of extracellular adenosine
mightpreventdetectionofadenosinereleasedinrelatively
small amounts during ‘normal’ physiological activity. It
was shown previously that adenosine levels in the rat
striatum were markedly higher (∼20-fold) shortly after
implantationofthemicrodialysisprobeascomparedwith
24hafterthesurgery(Pazzaglietal.1993).Itispossiblethat
the amount of cellular damage produced during sensor
placement varied markedly between animals. Therefore,
a higher baseline concentration of adenosine produced
through greater tissue damage may be responsible for our
inability to detect its release in some of the animals. Since
adenosine sensors were gradually losing their sensitivity
after placements into the hypothalamus (∼60% in 4h) it
was impossible to preimplant the sensors and conduct the
experiments on the next day.
However, in the three animals that displayed adenosine
release in response to LPS, the peak increase in
concentrationandtime-courseofreleasewereremarkably
consistent. The increase in adenosine concentration
occurred some 55min and peaked ∼3h after LPS
challenge. Thus, the increase in adenosine concentration
commenced some 37min after the onset of ATP release.
As ATP is usually broken down to adenosine quite
rapidly, this difference in time-course suggests that the
production of adenosine during systemic inﬂammation is
unlikely to originate entirely from prior release of ATP.
It is not entirely surprising considering the ﬁndings by
Frenguelli et al. (2007) who demonstrated independent
and distinct mechanisms underlying release of ATP and
adenosine during brain ischaemia. On the other hand,
changesininosineconcentrationcloselyfollowedchanges
in adenosine levels, strongly suggesting that released
adenosine is rapidly converted to inosine.
Functional implications: ATP release in the anterior
hypothalamus and its role in the febrile response
during systemic inﬂammation
Fever is one of the most signiﬁcant symptoms of sickness.
It is induced and orchestrated by the central nervous
system, speciﬁcally by the preoptic area/anterior hypo-
thalamus. Pro-inﬂammatory cytokines such as IL-1β and
others induce the febrile response by their actions in the
anteriorhypothalamus(Kliretal.1994;Klugeretal.1995;
Gourineetal.1998).Consideringthevastamountofrecent
literature which implicates extracellular ATP in triggering
P2X7-mediated release of proinﬂammatory cytokines
(see introduction) we expected that ATP produced in
this part of the brain would be responsible for local
cytokine production and therefore would play an
important role in the development of the febrile
response during systemic inﬂammation. This hypothesis
has received further recent support from evidence
demonstrating a marked up-regulation in P2X7 receptor
expressioninthebrainfollowingperipheralLPSchallenge
(Choietal.2007)andourrecentobservationthatsystemic
blockadeofP2X7 receptorsattenuatesfebrileandcytokine
responses evoked by LPS in rats (Gourine et al. 2005c).
However, our data in the present study do not support
this hypothesis. Although, ATP is indeed released in the
anterior hypothalamus during systemic inﬂammation,
localized blockade of P2 and speciﬁcally P2X7 receptors
(at the site of ATP release in the anterior hypothalamus)
did not reduce the febrile response. Instead, all three
ATP receptor antagonists tested (PPADS, BBG and oATP)
markedly augmented and prolonged the febrile response.
Activation of different P2X and P2Y receptor subtypes is
knowntodependuponextracellularconcentrationofATP
(McLarnon, 2005). In this study the peak increase in ATP
concentration (∼4μm) recorded by the biosensors was
well below the levels of ATP generally required to activate
P2X7 receptors (in excess of 1mm)( H i d eet al. 2000;
McLarnon,2005).WethereforeconcludethatATPreleased
in the anterior hypothalamus is unlikely to play any
major role in triggering production of proinﬂammatory
cytokines and, by extension, is unlikely to be involved in
facilitating the development of fever.
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Conversely, our data suggest a different, but equally
important,roleforATP-mediatedsignallingintheanterior
hypothalamus during the development of the febrile
response. The signiﬁcantly augmented and prolonged
feversthatoccurredwhentheactionofATPwasblockedby
antagonists suggest that ATP normally acts in the anterior
hypothalamus to limit the magnitude and duration of the
febrile response.
However, ATP release is relatively transient (it reaches
a peak some 45min following the LPS challenge and
decreases back to baseline within 120min). The effects of
theP2receptorantagonistsadministeredintotheanterior
hypothalamusonTbforthemostpartoccurredmuchlater
than this. Only BBG had a signiﬁcant early effect on the
febrile response – its effect on Tb was evident at 75min
after LPS injection. PPADS and oATP had signiﬁcant
effects on the febrile response starting from 150min
and 240min after induction of systemic inﬂammation,
respectively.
Actions of ATP receptor antagonists in the posterior
hypothalamus had very little effect on the LPS-induced
febrile response. Only oATP (in a higher dose of 100μg)
resulted in a small potentiation of fever at the very late
stagesofthefebrileresponse.Thissmalleffectofthehigher
dose might be either due to a diffusion of the antagonist
away from the injection site and its action at the anterior
hypothalamic structures, or due to some non-speciﬁc
action of the higher dose.
These data suggest that transient release of ATP in
the anterior hypothalamus during the initial phase of
systemicinﬂammationtriggersalongerlastingmechanism
thatsubsequentlylimitsthefebrileresponse.Interestingly,
there is evidence that ATP in the low micromolar range
(similar to that detected in this study) may inhibit
cytokine(includingIL-1β)productionbyculturedmicro-
glia via its actions at metabotropic P2Y receptors (Ogata
et al. 2003). Inhibition of cytokine production by ATP
released in the anterior hypothalamus could therefore be
responsible for limiting the febrile response. We believe
that this is unlikely. Although, PPADS may inhibit certain
P2Y receptors, the effects of either BBG or oATP on
P2Y receptors have not been described. In addition, our
preliminary studies in rats revealed no signiﬁcant effect
of PPADS on IL-1β expression in the hypothalamus
during LPS-induced systemic inﬂammation in rats (A.
V. Gourine, D. M. Poputnikov, R. Gerstberger & V. N.
Gourine, unpublished observations).
Alternatively, transient ATP release could conceivably
trigger activation of one or more of the hypothalamic
endogenous antipyretic systems which include release
of the known central fever-reducing substances such
as glucocorticoids, arginine-vasopressin, α-melanocyte
stimulating hormone and nitric oxide (for recent review
see Roth, 2006). For example, the ability of ATP to
induce hypothalamic release of vasopressin – one of
the most potent endogenous antipyretics – is well
documented (Kapoor & Sladek, 2000). There is also
evidence from the study involving our laboratory of a
widespread co-localization of neuronal NO synthase and
P2X receptors in the hypothalamus (Yao et al. 2003).
Conceivably, ATP may trigger NO production which has
beenshowntohaveanantipyreticcentralactioninrabbits
(Gourine,1995;Riedel,1997)aswellasinotherspecies(for
areviewseeSteiner&Branco,2003).Ifthereisanextended
time delay in the action of these systems following their
activationviaATPrelease,thismayexplainthedelayedand
longlastingeffectofP2antagonistsonthedevelopmentof
the febrile response. Distinct mechanisms underlying the
ﬁrst and second phases of fever (see for example Steiner
et al. 2006) may also account for the delayed effect of
ATP receptor antagonists on the late phase of the febrile
response.
Our data cast doubt on a role of P2X7 receptors in
mediating the hypothalamic effects of ATP on fever. BBG
and oATP were chosen for this study as they efﬁciently
antagonize P2X7 receptors (Ralevic & Burnstock, 1998;
North, 2002). P2X7 receptors are signiﬁcantly less
sensitive to blockade by the generic P2 antagonist PPADS
(IC50 ∼50μm), therefore this compound was used for
comparison. However, the effects of BBG and PPADS on
Tb during fever were not radically different. The effect of
oATP was slightly less profound but qualitatively similar
to that of PPADS. However, BBG and oATP are not
just P2X7 receptor antagonists. BBG is effective at the
rat P2X2 and human P2X4 receptors while oATP in the
micromolar range partially (60%) reduces currents at
P2X1 and P2X2 receptors (for review see North, 2002).
Interestingly,BBGandPPADSappeartobeequallypotent
in blocking P2X2 currents (North, 2002), suggesting that
P2X2 subunit-containing receptors may be the most likely
candidates to mediate the effects of ATP on the febrile
response.IndeedP2X2 receptorsubunits(alongwithP2X4
andP2X6)arethemostabundantATPreceptorsexpressed
by CNS neurones (North, 2002; Khakh & North, 2006)
and have a widespread distribution throughout the hypo-
thalamus (Xiang et al. 1998; Loesch et al. 1999; Kanjhan
et al. 1999; Yao et al. 2003).
Perspectives
Receptors for extracellular ATP – both ionotropic P2X
and metabotropic P2Y – are widely expressed in the
CNS both in neurones and glia. ATP has been found to
modulate neuronal activity in many parts of the brain
and to contribute to the central nervous control of many
physiological functions. In this study performed in
consciousrabbitsweobservedthatduringdevelopmentof
thesystemicinﬂammationtheextracellularconcentration
of ATP markedly increases in the anterior hypothalamus.
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Whenreleased,ATPactslocallytolimitthemagnitudeand
duration of the febrile response. These data demonstrate
the importance of directly measuring neurotransmitter
release, rather than inferring it from the effect of
antagonists on a particular physiological process – this
study demonstrated that during fever, ATP release occurs
signiﬁcantly before any effects of P2 antagonists on Tb are
observed.
Fever is just one of several behavioural and autonomic
adaptations that occur during the systemic inﬂammatory
response. Others include a decrease in locomotor activity,
sleepiness,malaiseandlossoffoodappetite.Itisintriguing
to speculate about the degree to which locally released
ATPandadenosine(speciﬁctothepreopticareas/anterior
hypothalamus) play a role in the development of these
responses. For example, the cholinergic basal forebrain
and the ventrolateral preoptic area – both involved in the
control of sleep (Saper et al. 2001; Basheer et al. 2004) –
are close to the areas of ATP and adenosine release. As
adenosine can act at these sites to promote sleep (Basheer
etal.2004;Morairtyetal.2004),thismaypartiallyexplain
why systemic inﬂammation is often accompanied by an
increased sleep drive. In addition, it will be important to
establish the cellular origin of ATP and adenosine release
(neurones or glial) as well as the mechanisms that cause
and mediate their release.
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